Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2)

被引:0
作者
Aljabry, Mansour S. [1 ,2 ]
机构
[1] King Saud Univ, Pathol Dept, Coll Med, POB 2925, Riyadh 11461, Saudi Arabia
[2] King Saud Univ, Med Coll, POB 2925, Riyadh 11461, Saudi Arabia
关键词
Myeloproliferative neoplasm; Eosinophilia; T-Lymphoblastic lymphoma; FGFR1; LEUKEMIA; PDGFRA;
D O I
10.1007/s12308-022-00528-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myeloid and lymphoid neoplasms with eosinophilia (M/Ls-Eo) encompass heterogeneous but aggressive hematopoietic disorders triggered by fusion genes or mutations that typically lead to constitutive overexpression of tyrosine kinase. The occurrence of T-lymphoblastic lymphoma in the setting of M/Ls-Eo has been reported rarely in the literature. Herein, we present an unusual case of a 28-year-old male patient who presented with massive lymphadenopathy and T-lymphoblastic lymphoma in the lymph node occurring concurrently with myeloid hyperplasia, eosinophilia and basophilia in peripheral blood and bone marrow biopsy. The syndrome was associated with a novel complex karyotype involving der(8)t(1;8;10)(p31;q24;q11.2). The FISH study was negative for BCR::ABL1, JAK2, PDGFRA, PDGFRB, and FGFR1 rearrangements. The patient's clinical course was aggressive and resistant to multiple lines of intensive chemotherapy regimens. Therefore, he underwent allogenic stem cell transplantation with a fully matched donor. A brief review of the occurrence of T-LBL in conjunction with M/Ls-Eo neoplasm was made with a special focus on molecular aspects.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 18 条
[1]   T-CELL LYMPHOBLASTIC LYMPHOMA WITH EOSINOPHILIA ASSOCIATED WITH SUBSEQUENT MYELOID MALIGNANCY [J].
ABRUZZO, LV ;
JAFFE, ES ;
COTELINGAM, JD ;
WHANGPENG, J ;
DELDUCA, V ;
MEDEIROS, LJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (03) :236-245
[2]  
Antic DA, 2016, J BUON, V21, P745
[3]   Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 [J].
Bain, Barbara J. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :696-698
[4]   RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation [J].
Ballerini, P. ;
Struski, S. ;
Cresson, C. ;
Prade, N. ;
Toujani, S. ;
Deswarte, C. ;
Dobbelstein, S. ;
Petit, A. ;
Lapillonne, H. ;
Gautier, E-F ;
Demur, C. ;
Lippert, E. ;
Pages, P. ;
Mansat-De Mas, V. ;
Donadieu, J. ;
Huguet, F. ;
Dastugue, N. ;
Broccardo, C. ;
Perot, C. ;
Delabesse, E. .
LEUKEMIA, 2012, 26 (11) :2384-2389
[5]  
Chan J, 2022, WHO CLASSIFICATION H
[6]   Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment [J].
Cowell, John K. ;
Hu, Tianxiang .
CANCER DRUG RESISTANCE, 2021, 4 (03) :607-619
[7]   The WHO Classification of Haematolymphoid Tumours [J].
Cree, Ian A. .
LEUKEMIA, 2022, 36 (07) :1701-1702
[8]   A SYNDROME OF LYMPHOBLASTIC LYMPHOMA, EOSINOPHILIA, AND MYELOID HYPERPLASIA MALIGNANCY ASSOCIATED WITH T(8-13) (P11-Q11) - DESCRIPTION OF A DISTINCTIVE CLINICOPATHOLOGICAL ENTITY [J].
INHORN, RC ;
ASTER, JC ;
ROACH, SA ;
SLAPAK, CA ;
SOIFFER, R ;
TANTRAVAHI, R ;
STONE, RM .
BLOOD, 1995, 85 (07) :1881-1887
[9]   Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia [J].
Kasbekar, Monica ;
Nardi, Valentina ;
Dal Cin, Paola ;
Brunner, Andrew M. ;
Burke, Meghan ;
Chen, Yi-Bin ;
Connolly, Christine ;
Fathi, Amir T. ;
Foster, Julia ;
Macrae, Molly ;
McAfee, Steven L. ;
McGregor, Kristin ;
Narayan, Rupa ;
Ramos, Aura Y. ;
Som, Tina T. ;
Vartanian, Meghan ;
Friedman, Robb S. ;
Benhadji, Karim A. ;
Hobbs, Gabriela S. .
BLOOD ADVANCES, 2020, 4 (13) :3136-3140
[10]   Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome [J].
Li, Feng ;
Zhai, Yong-Ping ;
Tang, Yu-Mei ;
Wang, Li-Ping ;
Wan, Pin-Jun .
GENES CHROMOSOMES & CANCER, 2012, 51 (09) :890-897